Docebo Overview
Docebo Target Price
Docebo target price — quarterly history, peer benchmarks, and growth trends.
Get informed when a big investor buys or sells
+ FollowShare Price
$23.42
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-03-02 | Canaccord GenuityRobert Young | $36 |  53.7% upside |  |
| 2026-03-02 | Craig-HallumGeorge Sutton | $38 | 62.3% upside | |
| 2026-01-30 | Scotiabank | $32 | 36.6% upside | |
| 2026-01-29 | OppenheimerKen Wong | $25 | 6.7% upside | |
| 2026-01-21 | Cantor FitzgeraldMatthew VanVliet | $28 | 19.6% upside | |
| 2025-11-10 | Morgan Stanley | $28 | 19.6% upside | |
| 2025-11-05 | OppenheimerKen Wong | $35 | 49.4% upside | |
| 2025-10-29 | CIBC | $36 | 53.7% upside | |
| 2025-10-03 | TD Securities | $37 | 58% upside | |
| 2025-04-16 | Morgan StanleyJosh Baer | $41 | 75.1% upside | |
| 2025-03-04 | UBS | $45 | 92.1% upside | |
| 2025-02-28 | Morgan Stanley | $43 | 83.6% upside | |
| 2024-10-24 | ScotiabankKevin Krishnaratne | $55 | 134.8% upside | |
| 2024-09-16 | Goldman SachsKevin Kumar | $48 | 105% upside | |
| 2024-09-12 | NeedhamRyan MacDonald | $50 | 113.5% upside | |
| 2024-08-09 | Canaccord GenuityRobert Young | $54 | 130.6% upside | |
| 2024-06-07 | Craig-HallumGeorge Sutton | $58 | 147.7% upside | |
| 2024-05-14 | Canaccord GenuityRobert Young | $55 | 134.8% upside | |
| 2024-05-14 | ScotiabankKevin Krishnaratne | $50 | 113.5% upside | |
| 2023-11-14 | NeedhamRyan MacDonald | $56 | 139.1% upside | |
| 2023-08-18 | Morgan StanleyJosh Baer | $49 | 109.2% upside | |
| 2022-11-11 | Morgan Stanley | $36 | 53.7% upside | |
| 2022-04-26 | Morgan Stanley | $54 | 130.6% upside | |
| 2021-08-13 | Cantor FitzgeraldBrett Knoblauch | $82 | 250.1% upside | |